Markets:

Overview

News

Currencies

International

Treasuries

Phathom Pharmaceuticals, Inc. - Common Stock (NQ:PHAT)

14.96 +0.60 (+4.14%)

Streaming Delayed Price Updated: 3:15 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Phathom Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT

May 21, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Analyst Expectations for Phathom Pharmaceuticals's Future ↗

May 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023 ↗

May 11, 2023

Via Benzinga

Phathom Pharmaceuticals Reports First Quarter 2023 Results

May 10, 2023

From Phathom Pharmaceuticals

Via GlobeNewswire

Where Phathom Pharmaceuticals Stands With Analysts ↗

April 05, 2023

Via Benzinga

Where Phathom Pharmaceuticals Stands With Analysts ↗

March 13, 2023

Via Benzinga

Phathom Pharmaceuticals Presents New Data at Digestive Disease Week® (DDW) 2023

May 09, 2023

From Phathom Pharmaceuticals

Via GlobeNewswire

ROSEN, A LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT

April 16, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Phathom Pharmaceuticals Inc. (NASDAQ: PHAT) Near the Top of Equities by Percentage Gain on 4/13

April 13, 2023

Via Investor Brand Network

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

April 12, 2023

From Phathom Pharmaceuticals

Via GlobeNewswire

Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks ↗

April 12, 2023

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT

April 09, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 04, 2023

Via Benzinga

Phathom Pharmaceuticals Announces Regulatory Update and Plans for 2023 Erosive Esophagitis and H. pylori Commercial Launch

April 04, 2023

From Phathom Pharmaceuticals

Via GlobeNewswire

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 30, 2023

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023 ↗

March 13, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 24, 2023

On Friday, 469 companies hit new 52-week lows.

Via Benzinga

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT

March 09, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT

March 06, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT

March 04, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

TOP RANKED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT

March 01, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

February 28, 2023

From Phathom Pharmaceuticals

Via GlobeNewswire

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT

February 26, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation - PHAT

February 19, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) Investor Alert: Investigation over Potential Wrongdoing ↗

February 17, 2023

San Diego, CA -- (SBWIRE) -- 02/17/2023 -- An investigation on behalf of investors in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT) was announced over potential breaches of fiduciary duties by...

Via SBWire

$14M Bet On This Technology Stock? Check Out These 4 Stocks Insiders Are Buying ↗

February 15, 2023

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

Via Benzinga

GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation – PHAT

February 14, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

One Analyst Is Bullish While Another Sees Overhang On Phathom Pharma Stock After Two Rejection Letters ↗

February 10, 2023

FDA issued two Complete Response Letters to Phathom Pharmaceuticals Inc's (NASDAQ: PHAT) vonoprazan marketing application for the erosive esophagitis (EE) indication and H. pylori (HP) indication...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 10, 2023

Via Benzinga

Why Hempacco Are Trading Lower By 58%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

February 10, 2023

Gainers SeqLL Inc. (NASDAQ: SQL) shares jumped 120% to $1.85 after dropping around 39% on Thursday. SeqLL recently announced the establishment of a two-year Cooperative Research and Development...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Phathom Pharmaceuticals, Inc. - Common Stock (NQ:PHAT)

All News about Phathom Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today